Skip to content

Drug interactions

Ceritinib + Octreotide

Severity: Major

Ceritinib and Octreotide: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ceritinib prolongs the QT interval and can cause bradycardia, and octreotide has similar effects on heart rate and conduction. Together they may increase the risk of torsades de pointes.

What this interaction means in plain words

Ceritinib and Octreotide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Ceritinib belongs to Oncology; Octreotide belongs to Endocrine.

Evidence level: Moderate

Why it happens

Additive QTc prolongation and bradycardia.

What to do

Avoid if possible; otherwise monitor ECG and electrolytes regularly and correct potassium and magnesium, reducing the ceritinib dose or interrupting it if QTc becomes markedly prolonged.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ceritinib and Octreotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ceritinib with Octreotide?

MediHelp rates the interaction as major. Ceritinib and Octreotide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ceritinib prolongs the QT interval and can cause bradycardia, and octreotide has similar effects on heart rate and conduction. Together they may increase the risk of torsades de pointes.

How serious is the interaction between Ceritinib and Octreotide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible; otherwise monitor ECG and electrolytes regularly and correct potassium and magnesium, reducing the ceritinib dose or interrupting it if QTc becomes markedly prolonged.

What other medicines interact with Octreotide?

MediHelp also lists interactions of Octreotide with, for example, Adagrasib, Amisulpride, Arsenic trioxide. The full list is on the Octreotide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in